company background image
A086060 logo

GeneBioTech Ltd KOSDAQ:A086060 Stock Report

Last Price

₩3.46k

Market Cap

₩29.7b

7D

3.6%

1Y

-19.7%

Updated

21 Nov, 2024

Data

Company Financials

GeneBioTech Co. ,Ltd

KOSDAQ:A086060 Stock Report

Market Cap: ₩29.7b

A086060 Stock Overview

Engages in the manufacture and sale of feed additives and functional food in South Korea. More details

A086060 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health5/6
Dividends0/6

GeneBioTech Co. ,Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for GeneBioTech Ltd
Historical stock prices
Current Share Price₩3,455.00
52 Week High₩4,745.00
52 Week Low₩3,125.00
Beta0.47
11 Month Change0.14%
3 Month Change-7.50%
1 Year Change-19.65%
33 Year Change-40.02%
5 Year Change-46.85%
Change since IPO-59.40%

Recent News & Updates

GeneBioTech Ltd's (KOSDAQ:086060) Soft Earnings Are Actually Better Than They Appear

Nov 21
GeneBioTech Ltd's (KOSDAQ:086060) Soft Earnings Are Actually Better Than They Appear

Market Cool On GeneBioTech Co. ,Ltd's (KOSDAQ:086060) Earnings

Aug 12
Market Cool On GeneBioTech Co. ,Ltd's (KOSDAQ:086060) Earnings

We Like The Quality Of GeneBioTech Ltd's (KOSDAQ:086060) Earnings

Mar 22
We Like The Quality Of GeneBioTech Ltd's (KOSDAQ:086060) Earnings

Recent updates

GeneBioTech Ltd's (KOSDAQ:086060) Soft Earnings Are Actually Better Than They Appear

Nov 21
GeneBioTech Ltd's (KOSDAQ:086060) Soft Earnings Are Actually Better Than They Appear

Market Cool On GeneBioTech Co. ,Ltd's (KOSDAQ:086060) Earnings

Aug 12
Market Cool On GeneBioTech Co. ,Ltd's (KOSDAQ:086060) Earnings

We Like The Quality Of GeneBioTech Ltd's (KOSDAQ:086060) Earnings

Mar 22
We Like The Quality Of GeneBioTech Ltd's (KOSDAQ:086060) Earnings

Read This Before Buying GeneBioTech Co. ,Ltd (KOSDAQ:086060) For Its Dividend

Apr 15
Read This Before Buying GeneBioTech Co. ,Ltd (KOSDAQ:086060) For Its Dividend

Should GeneBioTech Ltd (KOSDAQ:086060) Be Disappointed With Their 90% Profit?

Mar 18
Should GeneBioTech Ltd (KOSDAQ:086060) Be Disappointed With Their 90% Profit?

Here's Why Genebiotech (KOSDAQ:086060) Has A Meaningful Debt Burden

Feb 17
Here's Why Genebiotech (KOSDAQ:086060) Has A Meaningful Debt Burden

How Does Genebiotech Co., Ltd. (KOSDAQ:086060) Fare As A Dividend Stock?

Jan 10
How Does Genebiotech Co., Ltd. (KOSDAQ:086060) Fare As A Dividend Stock?

Is Genebiotech (KOSDAQ:086060) A Risky Investment?

Nov 19
Is Genebiotech (KOSDAQ:086060) A Risky Investment?

Shareholder Returns

A086060KR BiotechsKR Market
7D3.6%-4.5%2.4%
1Y-19.7%21.1%-4.0%

Return vs Industry: A086060 underperformed the KR Biotechs industry which returned 22.4% over the past year.

Return vs Market: A086060 underperformed the KR Market which returned -3.8% over the past year.

Price Volatility

Is A086060's price volatile compared to industry and market?
A086060 volatility
A086060 Average Weekly Movement3.3%
Biotechs Industry Average Movement8.0%
Market Average Movement5.6%
10% most volatile stocks in KR Market11.5%
10% least volatile stocks in KR Market2.7%

Stable Share Price: A086060 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A086060's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
200039Chan-Ho Leewww.genebiotech.co.kr

GeneBioTech Co. ,Ltd, together with its subsidiaries, engages in the manufacture and sale of feed additives and functional food in South Korea. It also manufactures and sells animal drugs. The company was founded in 2000 and is headquartered in Gongju-si, South Korea.

GeneBioTech Co. ,Ltd Fundamentals Summary

How do GeneBioTech Ltd's earnings and revenue compare to its market cap?
A086060 fundamental statistics
Market cap₩29.75b
Earnings (TTM)₩2.55b
Revenue (TTM)₩80.50b

11.7x

P/E Ratio

0.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A086060 income statement (TTM)
Revenue₩80.50b
Cost of Revenue₩67.72b
Gross Profit₩12.78b
Other Expenses₩10.23b
Earnings₩2.55b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)296.27
Gross Margin15.88%
Net Profit Margin3.17%
Debt/Equity Ratio30.7%

How did A086060 perform over the long term?

See historical performance and comparison